" /> Neoantigen-based Therapeutic Cancer Vaccine GRT-R904 - CISMeF





Preferred Label : Neoantigen-based Therapeutic Cancer Vaccine GRT-R904;

NCIt synonyms : Boosting Cancer Vaccine GRT-R904; Boosting Vaccine GRT-R904; Shared Neoantigen Boosting Cancer Vaccine GRT-R904; Shared Neoantigen Cancer Vaccine Boost GRT-R904;

NCIt definition : A cancer boosting vaccine consisting of tumor-specific shared neoantigens, which are immunogenic and unique across a subset of patients, with potential immunostimulating and antineoplastic activities. Upon administration of the neoantigen-based therapeutic cancer vaccine GRT-R904, which is administered after the initial administration of the priming vaccine GRT-C903, the peptides stimulate the host immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against the shared neoantigens expressed on tumor cells, which results in tumor cell lysis.;

Molecule name : GRT-R904; GRT R904;

NCI Metathesaurus CUI : CL978705;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.